| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| General and administrative | $7.6M+2.8% | $7.4M+35.5% | $5.4M-27.3% | $7.5M |
| Impairment of long-lived assets | $854K | $0 | — | — |
| Total operating expenses | $8.4M+14.4% | $7.4M-27.6% | $10.2M-54.1% | $22.2M |
| Operating loss | -$8.4M-14.4% | -$7.4M-79.9% | -$4.1M+71.5% | -$14.4M |
| Non-cash (loss) gain on changes in fair value of warrant liability | -$24.5M-21578.9% | $114K-58.1% | $272K-95.0% | $5.4M |
| Accretion of interest and amortization of discounts on convertible notes | -$277K+69.4% | -$904K+46.6% | -$1.7M | — |
| Other expense, net | -$20K+96.6% | -$581K-57.5% | -$369K-33.7% | -$276K |
| Net loss from continuing operations | -$33.2M-279.7% | -$8.8M-42.4% | -$6.1M | — |
| Net income from discontinued operations, net of taxes | $11.1M+625.7% | $1.5M+139.2% | -$3.9M | — |
| Net loss | -$22.1M-206.5% | -$7.2M+25.1% | -$9.6M+9.1% | -$10.6M |
| Less: Increase to accumulated deficit due to adjustment to common stock warrant exercise price | $0+100.0% | -$1.0M | $0 | — |
| Less: Increase to accumulated deficit due to adjustment to Preferred Stock conversion price | $0+100.0% | -$380K+94.6% | -$7.1M-224.7% | $5.7M |
| Net loss attributable to common stockholders | -$22.1M-157.2% | -$8.6M+49.3% | -$17.0M-4.3% | -$16.3M |
| Basic (and diluted for net loss) (in shares) | 5.8M+757.1% | 679K+465.8% | 120K+7353.4% | 2K |
| Basic loss per share from continuing operations (in dollars per share) | -$5700.00+61.8% | -$14930.00+86.4% | -$110020.00 | — |
| Basic earnings per share from discontinued operations (in dollars per share) | $1900.00-15.6% | $2250.00+107.7% | -$29120.00 | — |
| Basic (loss) earnings per share attributable to common stockholders (in dollars per share) | -$3800.00+70.0% | -$12680.00+90.9% | -$139140.00-1377523.8% | -$10.10 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.